Cochlear is a medical device company specializing in hearing implants.
Founded in Australia and listed on the ASX, the company holds over two-thirds of the worldwide hearing implant market.
Make a suggestion or report an error on this page: here
Share Price and Volume
Share Price and Volume
This is meant as a quick reference to compare against the other metrics, not as an advanced or accurate share price chart - the share price may be delayed by a day, and the volume by a couple of days.
Global Rank compares a website's popularity to all global websites eg. 100,000th most popular website in the world.
Local Rank is the website's popularity compared to all global websites, but ranked by Australian or US visitors eg. 1000th most popular website in Australia.
They use logarithmic scales, so a moderate improvement in the rankings can suggest a strong improvement in website traffic. The ranking is calculated based on a combination of today's traffic and the traffic from the past 90 days, so it is not entirely current, but partially backward looking.
This tracks Cochlear employees listed on Linkedin.
A change in trajectory could suggest a change in hiring, potenially due to an increase in scale. This is partially a trailing metric, as some employees will only update their Linkedin some weeks/months/years after joining the company.
Dec 15 - Feb 1 (Listed Employees: 4174 to 4198, +0.57%)
Brand Search Trends
Brand Search Trends
Can show if there is growth in brand searches for 'Cochlear'. Can also suggest an increase in market share, if searches grow faster than a competitor's brand searches eg. 'Pentax Medical'.
Consider this as a historical timeline of the company, and potentially giving insight into new features under development.
It is a non-exhaustive list of subdomains on the company website, ordered by when they were first found by our website. Can be indicative of new developments in progress, or new service offerings. Some subdomains may be private and inaccessible to the public, but you can still see the name.
See which directors have worked with the company over time. The 'First Seen' date is not the date that they were appointed, but the first date that we recorded them as a director.
Director
Position
First Seen
Ms Karen Lee Collett Penrose
Non Exec. Director
11 Jul 2022
Mr Michael del Prado
Non Exec. Director
12 Jan 2022
Mr Stuart Ross Sayers
CFO
14 Jan 2021
Ms Christine Frances McLoughlin
Non Exec. Director
11 Nov 2020
Mr Andrew Leslie Denver
Non Exec. Director
26 May 2020
Mr Brent Andrew Cubis
CFO
26 May 2020
Prof. Bruce Gregory Robinson
Non Exec. Director
26 May 2020
Ms Catriona Alison Deans
Chair, Non Exec. Director
26 May 2020
Mr Diggory William Howitt
President, CEO
26 May 2020
Mr Donal Paul O'Dwyer
Non Exec. Director
26 May 2020
Mr Glen Francis Boreham
Non Exec. Director
26 May 2020
Mr Michael Grenfell Daniell
Non Exec. Director
26 May 2020
Mr Ray Phillip Jarman
Company Secretary
26 May 2020
Mr Roderic Holliday-Smith
Chairman, Non Exec. Director
26 May 2020
Mr Shah Abbas Hussain
Non Exec. Director
26 May 2020
Ms Yasmin Anita Allen
Non Exec. Director
26 May 2020
Recent Company Comparisons
Recent Company Comparisons
See which companies people like to compare COH with. They may be similar companies that you'd also like to compare it against.
Disclaimer: Our main goal is to provide you with interesting and insightful charts and metrics. Our primary goal is not data reliability, and you should assume that the data is not 100% complete or accurate. Eg. our caching system could make some data hours or days outdated, or we could run into data collection issues. This website should be used as a tool to get you thinking about a company in new ways. It should not be used to make direct investment decisions, but to help you come up with ideas which you then confirm with primary data sources. We are not liable for any data errors, omissions, delays or interuptions, or any loss arising from its use, nor do we offer financial advice.
